Series B
The company will use the funds to speed up the commercialization of BiWaze Clear, scale U.S. sales initiatives, invest in clinical research and increase patient participation.
The firm plans to expand its chronic disease treatments across more therapeutic areas.
Funding will be used to expand the firm’s digital health platform.
Automata aims to scale capacities for life scientists.
Also, digital menopause start-up Bia Care expands NHS partnership.
Berlin-based digital health company plans to expand in the US market.
The digital health insurance provider confirmed it has closed one of the largest Series B rounds in the booming African healthtech industry to date.
Women’s health will be the focus of the new investment.
Investment proceeds will primarily fund FDA registration studies and opening of US headquarters.
Funding will enable the company to expand its app for chronic joint pain to the US and further across Europe.